iSpecimen (ISPC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
1 Feb, 2026Opening remarks and agenda
The 2025 annual meeting was called to order, welcoming all stockholders and introducing the board and management team.
The meeting was held virtually, with Broadridge Financial Solutions serving as inspector of election.
Overview of voting outcomes
An affidavit confirmed proper distribution of proxy materials to all stockholders of record.
A quorum was not present, preventing the conduct of official business or voting on proposals.
The meeting was adjourned to allow more time to obtain a quorum, with details of the reconvened meeting to be announced.
Corporate governance
The secretary of the meeting was present to record proceedings, and Broadridge's affidavit will be filed with the meeting minutes.
Partial view of Summaries dataset, powered by Quartr API
Latest events from iSpecimen
- Biospecimen marketplace raises $2.5M in private placement; large resale may impact share price.ISPC
Registration filing4 Jun 2026 - Key votes include director election, auditor ratification, and a new stock incentive plan.ISPC
Proxy filing18 May 2026 - Q1 2026 revenue plunged 85% and net loss deepened, raising going concern risks.ISPC
Q1 202618 May 2026 - Meeting adjourned without business due to lack of quorum; reconvening details to follow.ISPC
AGM 20268 May 2026 - 2025 revenue fell 79% to $1.93M, net loss improved to $10.49M, but going concern risks persist.ISPC
Q4 20251 Apr 2026 - No quorum was present, so the meeting was adjourned without conducting any business.ISPC
AGM 202613 Mar 2026 - Director resignation prompts amendment to election proposal ahead of rescheduled annual meeting.ISPC
Proxy Filing3 Mar 2026 - Q2 2024 revenue up 76% to $2.86M, net loss narrowed, but going concern risks remain.ISPC
Q2 20242 Feb 2026 - Registering 101M shares for resale after $5.5M raise; faces market risks and Nasdaq compliance challenges.ISPC
Registration Filing20 Jan 2026